Related Experiment Video
Updated: Jul 4, 2025

06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
32.3K
Predicting progression to Alzheimer's disease dementia using cognitive measures
Amy Macdougall1, Tim Whitfield2, Kelly Needham3
1Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
International Journal of Geriatric Psychiatry
|February 7, 2024
Summary
Cognitive tests like global function, memory, and psychomotor speed effectively predict Alzheimer's disease (AD) dementia in memory clinics. Tracking cognitive changes over time further enhances prediction accuracy for AD dementia.
Area of Science:
- Neurology
- Cognitive Science
- Geriatrics
Background:
- Cognitive measures prognostic in dementia research may have clinical utility in memory clinics.
- Identifying predictive cognitive measures is crucial for early Alzheimer's disease (AD) dementia detection, especially when biomarkers are unavailable.
Purpose of the Study:
- To identify cognitive measures with the highest predictive power for future Alzheimer's disease (AD) dementia in a memory clinic setting.
- To evaluate the utility of cognitive measures in predicting AD dementia progression in a real-world clinical environment.
Main Methods:
- Utilized 18 years of routine Memory Clinic data from 328 patients with subjective cognitive decline or mild cognitive impairment.
- Compared statistical models using baseline cognitive test scores versus models including both baseline and 1-year follow-up cognitive change scores.
- Assessed prediction of conversion to Alzheimer's disease (AD) dementia.
Main Results:
- Baseline scores on global cognitive function (Mini-mental state examination, Cambridge Cognitive Examination-Revised), verbal episodic memory, and psychomotor speed were the strongest predictors of AD dementia.
- Including cognitive change scores from 1-year follow-up significantly improved the accuracy of AD dementia prediction compared to baseline scores alone.
- The most effective cognitive predictors in a clinical setting align with those identified in research cohorts.
Conclusions:
- Cognitive measures effective in research cohorts are also valuable in memory clinic settings for predicting Alzheimer's disease (AD) dementia.
- Incorporating changes in cognitive function over time enhances the accuracy of predicting the onset of AD dementia.
- Routine cognitive assessments in memory clinics can aid in the early identification of individuals at risk for AD dementia.
Related Concept Videos
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Cognitive Development During Adulthood
111
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
111
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193

